Dr. Nazanin Alavi
14
5
5
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.1%
1 terminated/withdrawn out of 14 trials
88.9%
+2.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Online Relapse Prevention Therapy for Patients With Alcohol Use Disorder
Role: lead
Internet-Delivered Cognitive Behaviour Therapy for Women with Perimenopausal Anxiety
Role: lead
Comparing Clinical Decision-making of AI Technology to a Multi-professional Care Team in ECBT for Depression
Role: lead
Comparing the Efficacy of E-CBT to Mental Health Coaching for GAD
Role: lead
Online Delivery of Psychotherapy, Tailored to Patients' Suffering from Mental Health Problems Due to COVID-19
Role: lead
Investigating the Effectiveness of E-CBTi Compared to Pharmaceutical Interventions in Treating Insomnia
Role: lead
Delivering ICBT to Address Mental Health Challenges in Correctional Officers and Other Public Safety Personnel
Role: lead
Developing and Implementing E-psychotherapy Program for Mental Health Challenges in Oncology and Palliative Care
Role: lead
Delivering Electronic Cognitive Behavioural Therapy to Patients With Bipolar Disorder and Residual Depressive Symptoms
Role: lead
Incorporating Stepped Care Approach Into e-CBT for Depression
Role: lead
Using an Online Psychotherapy Program and AI-assisted Interventions for Postsecondary Student Mental Health
Role: lead
DBT Techniques by E-mail for Patients With BPD
Role: lead
Feasibility and Effectiveness of Delivering CBT Through OPTT for Depression
Role: lead
Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions
Role: lead
All 14 trials loaded